Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U19AI129910, U19AI129910, U19AI129910)
Wellcome Trust (107595/Z/15/Z, 107595/Z/15/Z, 107595/Z/15/Z)
Facultad de Ciencias, Universidad de los Andes (INV-2019-87-1793)
Received: 24 June 2022
Accepted: 11 August 2022
First Online: 3 November 2022
: The use of the clinical strains analyzed in this study was approved and monitored by the Institutional Review Board for Ethical Conduct of Research Involving Human Subjects of the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) under project code CIEIH 1291, following national and international guidelines for the conduct of clinical studies. Vector and reservoir sampling was approved by CICUAL and the ethics committee at Uniandes. All specimens were collected and processed as a part of the collection permit provided by the Colombian Ministry of Environment to Uniaversidad de los Andes.
: Not applicable.
: The authors declare that they have no competing interests.